Meeting
2012 ASCO Annual Meeting
Adjuvant chemotherapy (AC) initiation and early discontinuation in elderly patients (EPs) with stage III colon cancer (CC).
Authors
Jenny J Ko
British Columbia Cancer Agency, Vancouver, BC, Canada
Jenny J Ko , Hagen F. Kennecke , Howard John Lim , Sharlene Gill , Ryan Woods , Caroline Speers , Winson Y. Cheung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Health Services Research
Track
Health Services Research
Sub Track
Access to Care
Citation
J Clin Oncol 30, 2012 (suppl; abstr 6014)
DOI
10.1200/jco.2012.30.15_suppl.6014
Abstract #
6014
Poster Bd #
2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Impact of the IDEA collaboration study on practice patterns of adjuvant chemotherapy in patients with stage III colon cancer: A population-based study.
First Author: Sunil Samnani
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2017 ASCO Annual Meeting
PRODIGE 34 ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer—A randomized phase III trial.
First Author: Thomas Aparicio
Poster
2017 ASCO Annual Meeting
Surgeon and hospital variation in adjuvant chemotherapy delivery to patients with stage III colon cancer.
First Author: Zhaomin Xu